Vertex Pharmaceuticals (VRTX) Debt to Equity Ratio
Current and historical debt to equity ratio values for Vertex Pharmaceuticals (VRTX) over the last 10 years.
|Medical||Medical - Biomedical and Genetics||$39.504B||$2.489B|
|Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.|